Have any questions?
info@mpncancerconnection.org

Home
About
- Our team
- Info
Resources
- Partners
- Groups
MPN-CC Vision
Donate
- Corporate Sponsors
Blog
Contact

Groups

Home
Groups

Facebook Groups

MPNforum

MPN Interferon Forum

MPD - Myeloproliferative Disorders

Myelofibrosis Private Support Group

Polycythemia Vera Support Group

Polycythemia Vera Supportive Friends

New 2018 MPN Patient Guidelines

MPN Patient Guidelines for 2018, provided by National Comprehensive Cancer Network (NCCN). Click on the image above to view the Guidelines.

Sign up for our Newsletter

Subscribers will receive updates from MPN-CC and PV Reporter!

Email Address*

First Name*

Last Name*

* = required field

Pages

About
Blog
Contact
Corporate Sponsors
Donate
Donation Failed
Groups
Home
Info
MPN-CC Vision
Our team
Partners
Privacy
Resources
Terms

News

Safety and efficacy of combo therapy of interferon-a2 and ruxolitinib in polycythemia vera and myelofibrosis
03: Learn Benefits of Becoming your own MPN Patient Advocate
Spotlight on MPN Life
Cancer Survivor helping others – Newspaper article on David Wallace

Recent Posts

Risk of Myeloid Blood Cancers are increased in relatives of patients
MPN Patient Advocacy Works
ASH Partners with UNC, a ClinGen grantee to Curate Genomic data for Blood Research
Ruxolitinib Metformin combo: A Possible Alternative Treatment for Myeloproliferative Neoplasm Patients
How MPN Blood Cancers outsmart the Immune System
Imago BioSciences gets FDA Approval of IND Application for Treatment of Myelofibrosis, IMG-7289 in Clinical Trials

© 2016 MPN Cancer Connection. All Rights Reserved.

Terms
Privacy
Partners
About
Contact

Malcare WordPress Security